Fragile X syndrome neurons restored using CRISPR/Cas9-guided activation strategyEurekAlert (press release)Now for the first time, researchers at Whitehead Institute have restored activity to the fragile X syndrome gene in affected neurons using a modif… Continue reading
|
Chinese Doctors Are Using Modified T–Cells to Treat Advanced Forms of Cancer
Futurism But, as is also true of other forms of cancer, chemotherapy isn’t always successful. In China, and around the world, there’s a great need for the development of new treatments. Dr. Shixiu Wu, president of the Hangzhou Cancer Hospital, has tested a … |
hcanews.com |
Lost in the CRISPR Hype, a Gene-Editing Giant Is Fighting Back
hcanews.com … Sangamo have slowly been stocking freezers at their Bay Area headquarters with pairs of zinc fingers, the proteins that regulate gene expression. At one point, their technology was considered the cutting edge of genomic medicine, and Sangamo’s … |
Philadelphia Business Journal |
The partnership ushered in a new era of oncological care
Philadelphia Business Journal Novartis wasn’t sure where it was going to go.” CAR–T Cell therapy is a process that begins by drawing blood from a patient and separating out the T cells, which direct the body’s immune response for killing cells infected by pathogens. The T cells are … |
|
ICER Report: Costs of Approved CAR T-Cell Therapies Aligned With Clinical Benefit
AJMC.com Managed Markets Network CAR T-cell therapy has emerged as a novel way to treat cancer, genetically reprogramming a patient’s own white blood cells to attack tumor cells, and was recently named the American Society of Clinical Oncology’s Advance of the Year. Earlier this month … |